Summary
"Glioblastoma (GBM) remains the most common malignant primary brain tumour with a median survival
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/101151942 |
| Start date: | 01-01-2025 |
| End date: | 31-12-2026 |
| Total budget - Public funding: | - 172 750,00 Euro |
Cordis data
Original description
"Glioblastoma (GBM) remains the most common malignant primary brain tumour with a median survivalStatus
SIGNEDCall topic
HORIZON-MSCA-2023-PF-01-01Update Date
02-08-2025
Geographical location(s)
